TY - JOUR
T1 - Grand Challenges in global eye health
T2 - a global prioritisation process using Delphi method
AU - Grand Challenges in Global Eye Health study group
AU - Ramke, Jacqueline
AU - Evans, Jennifer R.
AU - Habtamu, Esmael
AU - Mwangi, Nyawira
AU - Silva, Juan Carlos
AU - Swenor, Bonnielin K.
AU - Congdon, Nathan
AU - Faal, Hannah B.
AU - Foster, Allen
AU - Friedman, David S.
AU - Gichuhi, Stephen
AU - Jonas, Jost B.
AU - Khaw, Peng T.
AU - Kyari, Fatima
AU - Murthy, Gudlavalleti V.S.
AU - Wang, Ningli
AU - Wong, Tien Y.
AU - Wormald, Richard
AU - Yusufu, Mayinuer
AU - Taylor, Hugh
AU - Resnikoff, Serge
AU - West, Sheila K.
AU - Burton, Matthew J.
AU - Aghaji, Ada
AU - Adewole, Adeyemi T.
AU - Csutak, Adrienne
AU - Salam, Ahmad Shah
AU - Paduca, Ala
AU - Bron, Alain M.
AU - Denniston, Alastair K.
AU - Lazo Legua, Alberto
AU - Halim, Aldiana
AU - Tefera, Alemayehu Woldeyes
AU - Mwangi, Alice
AU - Jenkins, Alicia J.
AU - Davis, Amanda
AU - Meddeb-Ouertani, Amel
AU - Wali, Amina H.
AU - Palis, Ana G.
AU - Bastos de Carvalho, Ana
AU - Joshi, Anagha
AU - Kreis, Andreas J.
AU - Mueller, Andreas
AU - Bastawrous, Andrew
AU - Cooper, Andrew
AU - Smith, Andrew F.
AU - Grzybowski, Andrzej
AU - Kitema, Gatera Fiston
AU - Khan, Imran A.
AU - Burr, Jennifer M.
N1 - Funding: The Lancet Global Health Commission on Global Eye Health is supported by The Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity (grant number GR001061), National Institute for Health Research Moorfields Biomedical Research Centre, Wellcome Trust, Sightsavers, The Fred Hollows Foundation, the Seva Foundation, and British Council for the Prevention of Blindness and Christian Blind Mission. MJB is supported by the Wellcome Trust (207472/Z/17/Z). JR's position at the University of Auckland is funded by the Buchanan Charitable Foundation, New Zealand.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Background We undertook a Grand Challenges in Global Eye Health prioritisation exercise to identify the key issues that must be addressed to improve eye health in the context of an ageing population, to eliminate persistent inequities in health-care access, and to mitigate widespread resource limitations. Methods Drawing on methods used in previous Grand Challenges studies, we used a multi-step recruitment strategy to assemble a diverse panel of individuals from a range of disciplines relevant to global eye health from all regions globally to participate in a three-round, online, Delphi-like, prioritisation process to nominate and rank challenges in global eye health. Through this process, we developed both global and regional priority lists. Findings Between Sept 1 and Dec 12, 2019, 470 individuals complete round 1 of the process, of whom 336 completed all three rounds (round 2 between Feb 26 and March 18, 2020, and round 3 between April 2 and April 25, 2020) 156 (46%) of 336 were women, 180 (54%) were men. The proportion of participants who worked in each region ranged from 104 (31%) in sub-Saharan Africa to 21 (6%) in central Europe, eastern Europe, and in central Asia. Of 85 unique challenges identified after round 1, 16 challenges were prioritised at the global level; six focused on detection and treatment of conditions (cataract, refractive error, glaucoma, diabetic retinopathy, services for children and screening for early detection), two focused on addressing shortages in human resource capacity, five on other health service and policy factors (including strengthening policies, integration, health information systems, and budget allocation), and three on improving access to care and promoting equity. Interpretation This list of Grand Challenges serves as a starting point for immediate action by funders to guide investment in research and innovation in eye health. It challenges researchers, clinicians, and policy makers to build collaborations to address specific challenges.
AB - Background We undertook a Grand Challenges in Global Eye Health prioritisation exercise to identify the key issues that must be addressed to improve eye health in the context of an ageing population, to eliminate persistent inequities in health-care access, and to mitigate widespread resource limitations. Methods Drawing on methods used in previous Grand Challenges studies, we used a multi-step recruitment strategy to assemble a diverse panel of individuals from a range of disciplines relevant to global eye health from all regions globally to participate in a three-round, online, Delphi-like, prioritisation process to nominate and rank challenges in global eye health. Through this process, we developed both global and regional priority lists. Findings Between Sept 1 and Dec 12, 2019, 470 individuals complete round 1 of the process, of whom 336 completed all three rounds (round 2 between Feb 26 and March 18, 2020, and round 3 between April 2 and April 25, 2020) 156 (46%) of 336 were women, 180 (54%) were men. The proportion of participants who worked in each region ranged from 104 (31%) in sub-Saharan Africa to 21 (6%) in central Europe, eastern Europe, and in central Asia. Of 85 unique challenges identified after round 1, 16 challenges were prioritised at the global level; six focused on detection and treatment of conditions (cataract, refractive error, glaucoma, diabetic retinopathy, services for children and screening for early detection), two focused on addressing shortages in human resource capacity, five on other health service and policy factors (including strengthening policies, integration, health information systems, and budget allocation), and three on improving access to care and promoting equity. Interpretation This list of Grand Challenges serves as a starting point for immediate action by funders to guide investment in research and innovation in eye health. It challenges researchers, clinicians, and policy makers to build collaborations to address specific challenges.
U2 - 10.1016/S2666-7568(21)00302-0
DO - 10.1016/S2666-7568(21)00302-0
M3 - Article
AN - SCOPUS:85123311028
SN - 2666-7568
VL - 3
SP - e31-e41
JO - The Lancet Healthy Longevity
JF - The Lancet Healthy Longevity
IS - 1
ER -
